1. Volume 64, Issue 1, Pages 118-140 (July 2013)
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction 
Matthias Oelke, Alexander Bachmann, Aurélien Descazeaud, Mark Emberton, Stavros Gravas, Martin C. Michel, James N'Dow, Jørgen Nordling, Jean J. de la Rosette 
European Urology 
Volume 64, Issue 1, Pages (July 2013)
DOI: /j.eururo
Copyright © 2013 European Association of Urology Terms and Conditions

2. Fig. 1
Multifactorial aetiology of lower urinary tract symptoms (LUTS). The European Association of Urology (EAU) guidelines on non-neurogenic male LUTS mainly covers LUTS secondary to benign prostatic enlargement (BPE) or benign prostatic obstruction (BPO), detrusor overactivity or overactive bladder (OAB), and nocturia due to nocturnal polyuria. Other causes of male LUTS are covered by separate EAU guidelines [3–7].
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions

3. Fig. 2
Treatment algorithm of male lower urinary tract symptoms (LUTS) using medical and/or conservative treatment options. Treatment decisions depend on results assessed during initial evaluation (◊).The absence (“No”) or presence of the condition (“Yes”) are indicated in circles (○). Note that patients’ preferences may result in different treatment decisions. PDE5-I=phosphodiesterase type 5 inhibitor.
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions

4. Fig. 3
Treatment algorithm of bothersome lower urinary tract symptoms (LUTS) refractory to conservative/medical treatment or in cases of absolute operation indications (eg, urinary retention, recurrent urinary tract infections, bladder stones or diverticula, treatment-resistant macroscopic haematuria, or dilatation of the upper urinary tract due to benign prostatic obstruction [BPO] with or without renal insufficiency). Note that this flowchart has been stratified by the patient's ability to have anaesthesia, cardiovascular risk, and prostate size; however, the choice of the surgical techniques also depends on the patient's preferences, willingness to accept surgery-associated side effects, availability of the armamentarium, and surgeon's experience with the operation technique. HoLEP=holmium laser enucleation of the prostate; laser vaporisation includes GreenLight, thulium, and diode lasers vaporisation; laser enucleation includes holmium and thulium laser enucleation; TUIP=transurethral incision of the prostate; TUMT=transurethral microwave therapy; TUNA=transurethral needle ablation of the prostate; TURP=transurethral resection of the prostate (monopolar or bipolar).
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions